Finerenone for Regression of Albuminuria in Type 2 Diabetes With Chronic Kidney Disease

NCT07667517 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

148

Enrollment

OTHER

Sponsor class

Conditions

Albuminuria
Type 2 Diabetes Mellitus (T2DM)
Chronic Kidney Diseases

Interventions

DRUG: Finerenone (BAY 94-8862)
DRUG: Placebo

Sponsor

First Affiliated Hospital of Zhejiang University